Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Kidney function may reveal hidden clues about high blood pressure

NCT ID NCT05114291

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 72 adults with high blood pressure to see if the concentration of their urine is linked to stiffness in their arteries. Researchers measured urine concentration, blood pressure, and arterial stiffness during a one-day hospital visit. The goal was to better understand how the kidneys and blood vessels affect each other in hypertension.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better understand how the kidneys and blood vessels interact in hypertension, potentially guiding future treatments.
What could go wrong
This is an observational study with only 72 participants, so results may not apply to everyone. It does not test a new treatment, so no direct benefit for patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

72 people

The number who actually took part.

Started

Dec 2021

Finished

Jul 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study concerns patients with hypertension who are addressed to a one-day hospitalization in order to realize standardized examinations (must include hormonal analyses : renin and aldosterone)

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults patients * Day hospitalization for a check-up in the context of arterial hypertension with suspicion of secondary origin including a dosage of renin and plasma aldosterone * Non-opposition to the study Exclusion Criteria: * Cardiac arrythmia * Patient under AME (state medical assistance) * Treatments interfering with uninterrupted hormonal dosages before day hospitalization * Absence of B-blockers, converting enzyme inhibitor and sartans in the 15 days preceding the dosages * Absence of antialdosterone, and amiloride in the 6 weeks preceding the dosages * Absence of loop diuretics or diuretics in the 7 days preceding the dosages

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertension

Contacts and locations

Locations

  • Centre Interdisciplinaire de Thérapeutique et d'Education APHP- Hôtel Dieu Hospital

    Paris, IDF, 75004, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.